European Review - Browse year 2004

• Eur Rev Med Pharmacol Sci 2004; 8 (6): 295-298
  Gastric emptying time in cyclic vomiting syndrome in children (PDF available)

  A. Turchetti, S. Guglielmi, C. Fossati, M. Matrunola, G. Corrado

• Eur Rev Med Pharmacol Sci 2004; 8 (6): 289-294
  Epidemiology of alternaria alternata allergy: a prospective study in 6840 italian asthmatic children (PDF available)

  A. Cantani, V. Ciaschi

• Eur Rev Med Pharmacol Sci 2004; 8 (6): 283-287
  Does rifaximin prevent complications of diverticular disease? A retrospective study (PDF available)

  M.A. Pistoia, L. Lombardi*, M. Rossi*, C. Vittorini, G.F. Cavaliere, F. Pistoia*

• Eur Rev Med Pharmacol Sci 2004; 8 (6): 275-281
  Fabry disease with special reference to neurological manifestations (PDF available)

  T.K. Banerjee

• Eur Rev Med Pharmacol Sci 2004; 8 (6): 265-274
  Spinal metastases: treatment evaluation algorithm (PDF available)

  A. Gasbarrini, M. Cappuccio, L. Mirabile, S. Bandiera, S. Terzi, G. Barbanti Bròdano, S. Boriani

• Eur Rev Med Pharmacol Sci 2004; 8 (6): 259-264
  Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness (PDF available)

  C. Terzano, A. Petroianni, A. Ricci, L. D’antoni, L. Allegra*

• Eur Rev Med Pharmacol Sci 2004; 8 (6): 247-258
  Therapeutic options for chronic obstructive pulmonary disease: present and future (PDF available)

  D.D. Sin

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 239-246
  Management of refractory fistulizing pouchitis with infliximab (PDF available)

  A. Viscido, A. Kohn*, C. Papi**, R. Caprilli

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 235-237
  Infliximab in the treatment of severe ulcerative colitis: a follow-up study (PDF available)

  A. Kohn, C. Prantera, A. Pera*, R. Cosintino, R. Sostegni*, M. Daperno*

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 231-233
  Infliximab in the treatment of steroid-dependent ulcerative colitis (PDF available)

  A. Armuzzi, B. De Pascalis, A. Lupascu, P. Fedeli, D. Leo, M.C. Mentella, F. Vincenti, D. Melina, G. Gasbarrini, P. Pola, A. Gasbarrini

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 230-0
  Infliximab in the treatment of steroid resistant/dependant and fistulating Crohn’s disease: an analysis of predictors of response in a italian multicentric open study in 573 patients

  A. Orlando1, E. Colombo2, A. Kohn3, L. Biancone4, A. Viscido5, R. Sostegni6, F. Rizzello7, L. Benazzato8, F. Castiglione9, C. Papi10, G. Meucci11, G. Rigler12, F. Mocciaro13, A. Lavagna6, M. Molteni2, D. Scimeca13, E. Angelucci5, C. Morselli7, A. Geremia4, G. Milite5, M. Cottone1

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 225-229
  Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment (PDF available)

  A. Belluzzi

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 219-224
  Small bowel Crohn’s disease: comparison of enteroclysis, bowel sonography and Tc-99m-HMPAO leukocyte scintigraphy (PDF available)

  A. Rispo, M. Imbriaco*, L. Celentano**, A. Cozzolino, P.P. Mainenti*, L. Camera*, E. Di Girolamo, T. De Falco, F. Castiglione

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 215-217
  Clinical correlations of small bowel CT and contrast radiology findings in Crohn’s disease (PDF available)

  L. Guidi, L.M. Minordi*, S. Semeraro, I. De Vitis, I. Roberto, S. Ennas, S. Guglielmo, L. Di Candia, A. Papa, R. Urgesi, A. Grillo, M.G. Brizi*, A. Vecchioli*, G. Fedeli

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 209-214
  The role of endoscopy in inflammatory bowel disease (PDF available)

  M. Daperno, R. Sostegni, A. Lavagna, L. Crocellà, E. Ercole, C. Rigazio, R. Rocca, A. Pera

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 205-208
  Exploring the relationships between inflammatory response and coagulation cascade in inflammatory bowel disease (PDF available)

  S. Saibeni, L. Spina, M. Vecchi

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 199-203
  Immunoglobulin M memory B cell decrease in inflammatory bowel disease (PDF available)

  A. Di Sabatino, R. Carsetti**, M.M. Rosado**, R. Ciccocioppo, P. Cazzola, R. Morera, F.P. Tinozzi*, S. Tinozzi*, G.R. Corazza

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 193-198
  Platelets: new players in the mucosal scenario of inflammatory bowel disease (PDF available)

  S. Danese, F. Scaldaferri, A. Papa, R. Pola, M. Sans*, G. Gasbarrini, P. Pola, A. Gasbarrini

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 192-192
  Enhanced expression of the Fas pathway inhibitor, Flip, in the mucosa of patients with Crohn’s disease (PDF available)

  I. Monteleone, L. Franchi*, L. Biancone, F. Pallone, G. Monteleone

• Eur Rev Med Pharmacol Sci 2004; 8 (5): 187-191
  Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease (PDF available)

  A. Papa, S. Danese, R. Urgesi, A. Grillo, S. Guglielmo, I. Roberto, S. Semeraro, F. Scaldaferri, R. Pola, A. Flex*, G. Fedeli, G. Gasbarrini, P. Pola*, A. Gasbarrini*